Liquid Biopsy Analysis of Circulating Tumor Biomarkers in Lung Cancer
Risk stratification, prognostication and longitudinal monitoring of therapeutic efficacy in lung cancer patients remains highly challenging. It is imperative to establish robust surrogate biomarkers for identifying eligible patients, predicting and effectively monitoring clinical response as well as...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book Chapter |
| Language: | English |
| Published: |
IntechOpen
2020
|
| Subjects: | |
| Online Access: | https://www.intechopen.com/chapters/74526 |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Liquid Biopsy Analysis of Circulating Tumor Biomarkers in Lung Cancer
- Liquid Biopsy: A New Strategy for Future Directions in Lung Cancer Treatment
- Circulating Methylated DNA as Biomarkers for Cancer Detection
- Diagnosis of Non-Small Cell Lung Cancer via Liquid Biopsy Highlighting a <em>Fluorescence-in-situ-Hybridization</em> Circulating Tumor Cell Approach
- Liquid Biopsy: A New Diagnostic Strategy and Not Only for Lung Cancer?
- Development of nanoparticle complexes as liquid biopsy candidates for circulating tumor cell detection
- Liquid Biopsy